IGF-2R-Gαq signaling and cardiac hypertrophy in the low-birth-weight lamb

Kimberley Wang, Darran N Tosh, Song Zhang, I Caroline McMillen, Jaime A Duffield, Doug A Brooks, Janna L Morrison

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The cardiac insulin-like growth factor 2 receptor (IGF-2R) can induce cardiomyocyte hypertrophy in a heterotrimeric G protein receptor-coupled manner involving αq (Gαq) or αs (Gαs). We have previously shown increased left ventricular weight and cardiac IGF-2 and IGF-2R gene expression in low-birth-weight (LBW) compared with average-birth-weight (ABW) lambs. Here, we have investigated the cardiac expression of IGF-2 gene variants, the degree of histone acetylation, and the abundance of proteins in the IGF-2R downstream signaling pathway in ABW and LBW lambs. Samples from the left ventricle of ABW and LBW lambs were collected at 21 days of age. There was increased phospho-CaMKII protein with decreased HDAC 4 abundance in the LBW compared with ABW lambs. There was increased GATA 4 and decreased phospho-troponin I abundance in LBW compared with ABW lambs, which are markers of pathological cardiac hypertrophy and impaired or reduced contractility, respectively. There was increased histone acetylation of H3K9 at IGF-2R promoter and IGF-2R intron 2 differentially methylated region in the LBW lamb. In conclusion, histone acetylation of IGF-2R may lead to increased IGF-2R mRNA expression and subsequently mediate Gαq signaling early in life via CaMKII, resulting in an increased risk of left ventricular hypertrophy and cardiovascular disease in adult life.

Original languageEnglish
Pages (from-to)R627-R635
Number of pages9
JournalAmerican Journal of Physiology: Regulatory, Integrative and Comparative Physiology
Volume308
Issue number7
DOIs
Publication statusPublished - 1 Apr 2015
Externally publishedYes

    Fingerprint

Cite this